The Merck Group Website
The Merck Group Website

Press Releases



2014
10/07/14 EMD Serono to Collaborate with The Institute of Cancer Research, London, and Wellcome Trust to Co-Develop Anti-Cancer Drugs
Rockland, Massachusetts
PDF
10/01/14 E MD Serono Announces Award of $1.3 Million to the Winners of the first Grant for Oncology Innovation
Rockland, Massachusetts
PDF
09/19/14 EMD Serono Awards Grant for Growth Innovation (GGI) for the first time
Rockland, Massachusetts
PDF
09/17/14 EMD Serono and Sutro Biopharma to Partner on Development of Antibody Drug Conjugates
Rockland, Massachusetts
PDF
09/12/14 EMD Serono Honors Recipients of the Second Annual €1 Million Grant for Multiple Sclerosis Innovation
Rockland, Massachusetts
PDF
09/10/14 EMD Serono and Accelerated Cure Project Launch Collaborative Research Program to Optimize Treatment and Understand Progression of Multiple Sclerosis
Rockland, Massachusetts
PDF
09/09/14 EMD Serono Presents New Data on Rebif ® (Interferon beta-1a) and Multiple Sclerosis Pipeline at Joint ACTRIMS-ECTRIMS Meeting in Boston
Rockland, Massachusetts
PDF
09/02/14 EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology
Rockland, Massachusetts
  PDF
09/02/14 EMD Serono and Massachusetts General Hospital Collaborate to Better Understand Systemic Lupus Erythematosus and Lupus Nephritis 
Billerica, Massachusetts
PDF
07/29/14 EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma
Rockland, Massachusetts
PDF
07/08/14 EMD Serono Participates in Global Grants Program to Fund Scientific Innovation and Medical Education  
Rockland, Massachusetts
  PDF
07/01/14 EMD Serono Commits € 2 million to the Grant for Fertility Innovation (GFI) for 2014 /15  
Rockland, Massachusetts
  PDF
06/24/14 EMD Serono and Mersana to Develop Next-Generation Antibody-Drug Conjugates
Rockland, Massachusetts
  PDF
06/11/14 EMD Serono Launches Compassionate Corps Program to Reduce Cost of Fertility Treatment for Eligible Military Veterans and their Spouses
Rockland, Massachusetts
  PDF
05/29/14 EMD Serono to Release New Pipeline Data at ASCO 2014 from Early-Stage Investigational Compounds in Difficult-to-Treat Cancers
Rockland, Massachusetts
  PDF
05/28/14 EMD Serono Data at CMSC & ACTRIMS Annual Meeting Reinforces Proven Efficacy of Rebif® (interferon beta-1a) and Demonstrates Continued Commitment to Patients with Relapsing MS
Rockland, Massachusetts
  PDF
04/25/14 EMD Serono Presents New Data on Rebif®  (interferon beta-1a) and Advancing MS Pipeline at AAN Annual Meeting
Rockland, Massachusetts
  PDF
04/07/14 EMD Serono Announces Initiation of Phase III START2 Study with Tecemotide in Stage III Non-Small Cell Lung Cancer
Rockland, Massachusetts
  PDF
04/01/14 EMD Serono, Inc. Launches 10th Edition of The EMD Serono Specialty Digest™ at Annual Meeting of The Academy of Managed Care Pharmacy
Rockland, Massachusetts
  PDF
04/01/14 EMD Serono Enters into Research Agreement with Pfizer and Broad Institute
Rockland, Massachusetts
  PDF
02/13/14 EMD Serono Strengthens Leadership With New Appointments
Rockland, Massachusetts
PDF

2013


12/17/13 EMD Serono, Inc. and the National MS Society Announce Recipients of Funding for Multiple Sclerosis Research  
Rockland, Massachusetts
English  
12/16/13 EMD Serono’s Redesigned Fertility Pen Available for Distribution in US  
Rockland, Massachusetts
English  
12/02/13 EMD Serono’s new spin - off TocopheRx to focus on infertility treatment  
Rockland, Massachusetts
English  
11/08/13 EMD Serono Announces Appointment of Paris Panayiotopoulos as President and Managing Director  
Rockland, Massachusetts
  English  
10/28/13 EMD Serono and Open Monoclonal Technology Expand Collaboration 
Rockland, Massachusetts
  English  
10/16/13 EMD Serono Receives FDA Approval for Redesigned Fertility Pen 
Rockland, Massachusetts
English  
10/05/13 EMD Serono Makes First Awards as Part of the Company’s €1 Million Grant for Multiple Sclerosis Innovation 
Rockland, Massachusetts
  English  
10/01/13 EMD Serono Exclusive Supporter of Newly Launched Multiple Sclerosis Resource Centre 
Rockland, Massachusetts
  English  
09/25/2013 EMD Serono Announces Decision to Continue the Development of Tecemotide in Stage III Non-Small Cell Lung Cancer 
Rockland, Masschusetts
  English  
09/10/2013 EMD Serono Chief Financial Officer Named to South Shore Hospital Board of Directors 
Rockland, Massachusetts
English  
08/30/2013 EMD Serono President and Head of US Operations James Hoyes Resigns 
Rockland, Massachusetts
  English  
07/09/2013 Commitment of €4 million made to the Grant for Fertility Innovation (GFI) for the years 2013 / 2014  
Rockland, Massachusetts
  English  
06/26/2013 EMD Serono Establishes Immuno - Oncology Research and Early Development Platform to Advance Innovation in Cancer Therapies  
Rockland, Massachusetts
  English  
05/28/2013 MS LifeLines® Call Center Earns J.D. Power and Associates Re-Certification for Customer Service Excellence in Providing Support Services to the MS Community 
Rockland, Massachusetts
  English  
05/16/2013 EMD Serono’s Affiliate Increases MS Ventures Commitment to € 100 Million  
Rockland, Massachusetts
  English  
04/15/2013 EMD Serono Expands Global Research & Development Hub in Massachusetts and Continues to Build Presence in US Pharmaceuticals Market 
Rockland, Massachusetts
  English  
04/15/2013 EMD Serono Announces Appeals Court Decision 
Rockland, Massachusetts
  English  
02/25/2013 EMD Serono: Phase III Trial of Cilengitide Did Not Meet Primary Endpoint in Patients With Newly Diagnosed Glioblastoma 
Rockland, Massachusetts
  English  
01/03/2013 EMD Serono and Pfizer Announce FDA Approval of Rebif® Rebidose® (interferon beta-1a) 
Rockland, Massachusetts/New York, NY
  English        
 

 

2012
12/20/2012 EMD Serono, Inc. and Fast Forward, LLC Announce Recipients of Funding for Multiple Sclerosis Research
Rockland, Massachusetts
   English
12/19/2012 EMD Serono: Phase III Trial of L-BLP25 (Stimuvax) in Patients with Non-Small Cell Lung Cancer Did not Meet Primary Endpoint
Rockland, Massachusetts
  English
10/18/2012 EMD Serono and Auxogyn Announce Collaboration on Eeva™ Test
Rockland, Massachusetts
  English
10/11/2012 EMD Serono Launches One Million Euro Research Grant for Multiple Sclerosis Innovation
Rockland, Massachusetts
  English
09/18/2012

EMD S erono Expands the Grant for Fertility Innovation (GFI) Program to Include  U.S. Investigators 
Rockland, Massachusetts

  English
07/31/2012 EMD Serono Announces Appointment of Dr. Thorsten Eickenhorst to US Leadership Team
Rockland, Massachusetts
  English
06/14/2012 EMD Serono, Inc. Strengthens Leadership Teams with New
Appointments
Rockland, Massachusetts
  English
05/23/2012 DR. ANNALISA JENKINS, EXECUTIVE VICE PRESIDENT, HEAD OF GLOBAL DRUG DEVELOPMENT AND MEDICAL FOR MERCK SERONO, HONORED BY GILDA’S CLUB NEW YORK CITY
Rockland, Massachusetts
  English
04/20/2012 EMD SERONO TO PRESENT NEW DATA ON MULTIPLE SCLEROSIS AT THE AMERICAN ACADEMY OF NEUROLOGY’S 64TH ANNUAL MEETING
Rockland, Massachusetts
  English
04/17/2012 EMD SERONO, INC. FOUNDING DONOR OF NEWLY LAUNCHED MGH MULTIPLE SCLEROSIS DISCOVERY FORUM
Rockland, Massachusetts
  English
01/23/2012 MS LIFELINES EARNS J.D. POWER AND ASSOCIATES CALL CENTER CERTIFICATION FOR CUSTOMER SERVICE EXCELLENCE IN PROVIDING SUPPORT SERVICES TO THE MS COMMUNITY
Rockland, MA/New York, NY
  English
2011
10/19/2011 EMD SERONO AND FAST FORWARD COMMIT $3 MILLION FOR MULTIPLE SCLEROSIS
Rockland, Massachusetts
  English
09/15/2011 EMD SERONO, INC. HONORED AS A 2011 WORKING MOTHER 100 BEST COMPANY
Rockland, Massachusetts
  English
07/14/2011 EMD SERONO, INC. ANNOUNCES APPOINTMENT OF JAMES HOYES AS PRESIDENT
Rockland, Massachusetts
  English
06/30/2011 EMD SERONO, INC. AND FAST FORWARD, LLC ANNOUNCE RECIPIENTS OF FUNDING FOR MULTIPLE SCLEROSIS RESEARCH
Rockland, Massachusetts / New York, New York
  English
06/23/2011 EMD SERONO INC. COMMITTED TO TRANSPARENCY IN INTERACTIONS WITH HEALTHCARE PROFESSIONALS AND ORGANIZATIONS
Rockland, Massachusetts
  English
06/09/2011 EMD SERONO: PATIENT ENROLLMENT COMPLETED FOR CILENGITIDE'S PIVOTAL PHASE III TRIAL CENTRIC
Rockland, Massachusetts
  English
05/20/2011 EMD SERONO PRESIDENT AND CEO FEREYDOUN FIROUZ RESIGNS
Rockland, Massachusetts
  English
05/04/2011 EMD SERONO, INC. ANNOUNCES CIVIL SETTLEMENT
Rockland, Massachusetts
  English
04/28/2011 EMD SERONO, INC. PROVIDES $1.5M GRANT TO MASSACHUSETTS GENERAL
Rockland, Massachusetts
  English
04/26/2011 EMD SERONO, INC. RECEIVES GOLD LEED RATING
Rockland, Massachusetts
  English
04/08/2011 EMD SERONO'S COMMITMENT TO ADVANCE MULTIPLE SCLEROSIS CARE AND RESEARCH UNDERSCORED BY DATA TO BE PRESENTED AT AAN 2011 MEETING
Rockland, Massachusetts
  English
03/24/2011 EMD SERONO, INC. RECEIVES CEO CANCER GOLD STANDARD™ ACCREDITATION
Rockland, Massachusetts
  English
03/02/2011 EMD SERONO RECEIVES COMPLETE RESPONSE LETTER FROM FDA ON CLADRIBINE TABLETS NEW DRUG APPLICATION
Rockland, Massachusetts
  English
02/10/2011 EMD SERONO HOLDS GRAND OPENING CEREMONY FOR NEW STATE-OF-THE-ART RESEARCH CENTER IN BILLERICA, MA
Rockland, Massachusetts
  English
2010
11/26/2010 EMD SERONO ANNOUNCES EXTENSION OF FDA PRIORITY REVIEW PERIOD FOR CLADRIBINE TABLETS FOR THE TREATMENT OF RELAPSING FORMS OF MULTIPLE SCLEROSIS
Rockland, Massachusetts
  English
11/11/2010 FDA APPROVES EGRIFTA (TESAMORELIN FOR INJECTION): FIRST AND ONLY TREATMENT FOR THE REDUCTION OF EXCESS ABDOMINAL FAT IN HIV-INFECTED PATIENTS WITH LIPODYSTROPHY
Rockland, Massachusetts
  English
10/08/2010 EMD SERONO, INC. NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE
Rockland, Massachusetts
  English
09/01/2010 MS LIFELINES REACHES MILESTONE OF SERVICING ONE MILLION IN-BOUND CALLS
Rockland, Massachusetts
  English
07/28/2010 EMD SERONO, INC.: FDA GRANTS PRIORITY REVIEW TO CLADRIBINE TABLETS FOR THE TREATMENT OF RELAPSING FORMS OF MS
Rockland, Massachusetts
  English
06/17/2010 EMD SERONO RESUMES STIMUVAX CLINICAL PROGRAM IN LUNG CANCER
Rockland, Massachusetts
  English
06/05/2010

CILENGITIDE STUDY PROVIDES LONG-TERM FOLLOW-UP DATA IN GLIOBLASTOMA PATIENTS 
Rockland, Massachusetts

  English
05/05/2010 EMD SERONO, INC. AND FAST FORWARD, LLC ANNOUNCE FIRST RESULTS OF THEIR COLLABORATION TO ADVANCE DRUG DEVELOPMENT IN MULTIPLE SCLEROSIS
Rockland, Massachusetts
  English
03/23/2010

EMD SERONO: STIMUVAX CLINICAL PROGRAM TEMPORARILY SUSPENDED
Geneva, Switzerland

English  
03/05/2010

EMD SERONO, INC. NAMED ONE OF THE BEST PLACES TO WORK IN INDUSTRY BY THE SCIENTIST MAGAZINE  
Rockland, Massachusetts

English  
1/21/2010 TWO-YEAR RESULTS FROM CLARITY STUDY WITH CLADRIBINE TABLETS IN MULTIPLE SCLEROSIS PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE
Rockland, Massachusetts
English
2009
12/16/2009 EMD SERONO, INC. AND NATIONALLY RANKED US HOSPITAL ANNOUNCE COLLABORATION IN BASIC AND CLINICAL RESEARCH IN MULTIPLE SCLEROSIS
Rockland, MA
  English
11/30/2009
EMD SERONO, INC. RECEIVES REFUSE TO FILE LETTER FROM FDA ON CLADRIBINE TABLETS NEW DRUG APPLICATION
Rockland, MA
  English
10/19/2009
EMD SERONO, INC. HOLDS TOPPING OFF CEREMONY TO MARK MILESTONE IN EXPANSION OF THE COMPANY'S BILLERICA, MA RESEARCH FACILITY
Rockland, MA
  English
10/05/2009
EMD SERONO, INC. NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE          
Rockland, MA
  English
09/30/2009
EMD SERONO SUBMITS APPLICATION FOR CLADRIBINE TABLETS AS A POTENTIAL ORAL SHORT-COURSE MULTIPLE SCLEROSIS THERAPY IN THE UNITED STATES          
Rockland, MA
  English
08/10/2009 EMD SERONO, INC. AND THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER ANNOUNCE COLLABORATION FOR PRECLINICAL RESEARCH, CLINICAL TRIALS         
Rockland, MA/Houston, TX
  Englis h
05/27/2009 MULTIPLE SCLEROSIS - WHAT ARE PEOPLE WITH MS AND THEIR HEALTH CARE PROVIDERS REALLY THINKING?          
Rockland, MA/New York, NY
  English
05/01/2009 EMD Serono, Inc. and Fast Forward, LLC Commit $3 Million in 2009 To Early Stage Drug Development For Multiple Sclerosis
Rockland, MA/New York, NY
  English
04/29/2009

TWO-YEAR PHASE III DATA PRESENTED AT AAN 61ST ANNUAL MEETING SHOW POSITIVE OUTCOME OF CLADRIBINE TABLETS IN PATIENTS WITH MULTIPLE SCLEROSIS
Rockland, Massachusetts

  English
03/30/2009 EMD SERONO: NEW PHASE III DATA FOR CLADRIBINE TABLETS TO BE PRESENTED AT THE AMERICAN ACademY OF NEUROLOGY 61ST ANNUAL MEETING IN APRIL 2009 
Rockland, Massachusetts
  English
03/30/2009

EMD SERONO ANNOUNCES EXPANSION WITH RESEARCH SITE IN CAMBRIdGE, MASSACHUSETTS
Rockland, Massachusetts

  English
03/18/2009 EMD SERONO and Fast Forward, LLC Announce Collaboration to Accelerate Development of Treatments for Multiple Sclerosis
Rockland, Massachusetts
  English
01/23/2009 EMD SERONO’S ORAL INVESTIGATIONAL TREATMENT CLADRIBINE TABLETS FOR MULTIPLE SCLEROSIS SIGNIFICANTLY REDUCED RELAPSE RATE IN TWO-YEAR PHASE III PIVOTAL TRIAL
Rockland, Massachusetts
  English
01/12/2009

EMD Serono and Emmaus Medical Announce Promotional Rights Agreement for Zorbtive® in the United States
Rockland, Massachusetts

  English
2008
11/07/2008 EMD SERONO LAUNCHES LANDMARK PATIENT REGISTRY FOR EGG FREEZING
Rockland, Massachusetts
  English
10/29/2008 EMD SERONO AND THERATECHNOLOGIES ANNOUNCE COLLABORATION AND LICENSING AGREEMENT FOR TESAMORELIN IN THE UNITED STATES
Rockland, Massachusetts
  English
10/9/2008 EMD SERONO NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE
Rockland, Massachusetts
  English
7/10/2008 EMD SERONO, INC. TO ADOPT REVISED AND STRENGTHENED PHRMA CODE
Rockland, Massachusetts
English
4/16/2008 EMD SERONO ANNOUNCES PLANNED INVESTMENT OF $50 MILLION IN RESEARCH CENTER IN MASSACHUSETTS
Geneva, Switzerland
English
2007
12/13/2007 EMD ANNOUNCES SUPPORT OF THE MICHAEL J. FOX FOUNDATION FOR PARKINSON’S RESEARCH
Geneva, Switzerland
English
12/6/2007 EMD SERONO LAUNCHES EASYPOD®, NEW ELECTRONIC GROWTH HORMONE INJECTION DEVICEGeneva, Switzerland English
7/2/2007 EMD SERONO LAUNCHES MS LIFELINES ACCESS MADE SIMPLE, A PROGRAM DESIGNED TO SIMPLIFY ACCESS TO MS THERAPY
Rockland, Massachusetts
English
2007
6/4/2007 MERCK SERONO S.A. TO TERMINATE REGISTRATION AND DUTY TO FILE REPORTS UNDER THE U.S. SECURITIES EXCHANGE ACT
Geneva, Switzerland
English
6/4/2007 CLOSING OF THE EXISTING SHARE-REPURCHASE PROGRAM OF UP TO CHF 750 MILLION BY JUNE 1, 2007
Geneva, Switzerland
English
4/5/2007 MERCK SERONO S.A. TO VOLUNTARILY DELIST AND DEREGISTER ITS BEARER SHARES AND AMERICAN DEPOSITARY SHARES (EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS)
Geneva, Switzerland
English
3/21/2007 MERCK INITIATES SQUEEZE OUT PROCEDURE FOR SHARES OF MERCK SERONO S.A.
Geneva, Switzerland
English
3/21/2007 MERCK SERONO CONFIRMS PREVIOUSLY ANNOUNCED 2006 FIGURES
Geneva, Switzerland
English
2/28/2007 MERCK KGAA HOLDS NEARLY ALL VOTING RIGHTS IN MERCK SERONO S.A.
Geneva, Switzerland
English
1/9/2007 MERCK KGaA ANNOUNCES PUBLIC TENDER OFFER FOR MERCK SERONO SHARES
Geneva, Switzerland
English
1/8/2007 MERCK SERONO IS LAUNCHED
Geneva, Switzerland
English
1/5/2007 MERCK KGAA ACQUIRES MARJORITY SHAREHOLDING IN SERONO S.A.
Geneva, Switzerland
English
 
top

MEDIA CONTACT

Lisa Buffington
Vice President
US Communications
EMD Serono, Inc.
Tel.:781-681-2340 

MEDIA KIT

Access PDF files and images relating to company facts, our leadership team, EMD Serono locations, and our therapeutic areas.